Search results for “Advanced Solid Tumor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 248 patents, we discovered top 32 key players by total patent application. Bristol Myers Squibb Co., Sanofi SA, Novartis AG are dominant in this area. They take 45.56% of the total patent filing.
Bristol Myers Squibb Co.
New York, United States
Patent: 55
Sanofi SA
France
Patent: 45
Novartis AG
Basel-Stadt, Switzerland
Patent: 13
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 11
Janssen Biotech
Belgium
Patent: 11
Agios Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 9
Celator Pharmaceuticals, Inc.
New Jersey, United States
Patent: 8
BicycleTx Ltd.
Cambridgeshire, United Kingdom
Patent: 7
Les Laboratoires Servier SAS
France
Patent: 5
STARTUP
Sumitomo Dainippon Pharma Oncology, Inc.
United States
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 9 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Sumitomo Dainippon Pharma Oncology, Inc.
United States
Patent: 5
STARTUP
SERVIER PHARMA LLC
Massachusetts, United States
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 119 patents applied in the last 5 years. We discover 25 most active companies in this area. The fast-growing Bristol Myers Squibb Co., Sanofi SA, Janssen Biotech take 46.22% of patent filing during this period.
Bristol Myers Squibb Co.
New York, United States
Patent: 26
Sanofi SA
France
Patent: 18
Janssen Biotech
Belgium
Patent: 11
BicycleTx Ltd.
Cambridgeshire, United Kingdom
Patent: 7
STARTUP
Sumitomo Dainippon Pharma Oncology, Inc.
United States
Patent: 5
Sumitomo Pharma Oncology, Inc.
Massachusetts, United States
Patent: 5
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 4
Replimune Ltd.
United Kingdom
Patent: 4
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 4
NGM Biopharmaceuticals, Inc.
California, United States
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 119 patents in last 5 years, we discover 20 new entrants. Janssen Biotech, BicycleTx Ltd., Sumitomo Dainippon Pharma Oncology, Inc. are the most active new entrants in this area.
Janssen Biotech
Belgium
Patent: 11
BicycleTx Ltd.
Cambridgeshire, United Kingdom
Patent: 7
STARTUP
Sumitomo Dainippon Pharma Oncology, Inc.
United States
Patent: 5
Sumitomo Pharma Oncology, Inc.
Massachusetts, United States
Patent: 5
Replimune Ltd.
United Kingdom
Patent: 4
BioNTech SE
Rheinland-Pfalz, Germany
Patent: 4
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 4
NGM Biopharmaceuticals, Inc.
California, United States
Patent: 3
Exelixis, Inc.
California, United States
Patent: 3
Purdue Research Foundation
Indiana, United States
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 4 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Brown University
Rhode Island, United States
Patent: 1
Université d'Aix-Marseille
France
Patent: 1
Regents of the University of Colorado
Colorado, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: